The prognostic value of HER2 status and efficacy of anti-HER2 therapy in patients with HR-positive mucinous breast cancer: a nationwide study from the Korean Breast Cancer Society. [electronic resource]
Producer: 20201123Description: 461-470 p. digitalISSN:- 1573-7217
- Adenocarcinoma, Mucinous -- drug therapy
- Antineoplastic Agents, Immunological -- therapeutic use
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant -- methods
- Estrogen Receptor alpha -- metabolism
- Female
- Humans
- Middle Aged
- Prognosis
- Receptor, ErbB-2 -- antagonists & inhibitors
- Receptors, Progesterone -- metabolism
- Republic of Korea
- Societies, Medical
- Survival Rate
- Trastuzumab -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.